These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. UKPDS 19: heterogeneity in NIDDM: separate contributions of IRS-1 and beta 3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. UK Prospective Diabetes Study. Zhang Y; Wat N; Stratton IM; Warren-Perry MG; Orho M; Groop L; Turner RC Diabetologia; 1996 Dec; 39(12):1505-11. PubMed ID: 8960833 [TBL] [Abstract][Full Text] [Related]
5. Insulin resistance: the fundamental trigger of type 2 diabetes. Groop LC Diabetes Obes Metab; 1999 May; 1 Suppl 1():S1-7. PubMed ID: 11220283 [TBL] [Abstract][Full Text] [Related]
7. Analysis of candidate genes in Polish families with obesity. Malczewska-Malec M; Wybranska I; Leszczynska-Golabek I; Partyka L; Hartwich J; Jabrocka A; Kiec-Wilk B; Kwasniak M; Motyka M; Dembinska-Kiec A Clin Chem Lab Med; 2004 May; 42(5):487-93. PubMed ID: 15202783 [TBL] [Abstract][Full Text] [Related]
8. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance. Højlund K Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125 [TBL] [Abstract][Full Text] [Related]
9. Genetics of visceral obesity and insulin resistance: relationship to non-insulin-dependent diabetes mellitus. Groop L Growth Horm IGF Res; 1998 Apr; 8 Suppl B():9-14. PubMed ID: 10990130 [No Abstract] [Full Text] [Related]
11. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. San Millán JL; Cortón M; Villuendas G; Sancho J; Peral B; Escobar-Morreale HF J Clin Endocrinol Metab; 2004 Jun; 89(6):2640-6. PubMed ID: 15181035 [TBL] [Abstract][Full Text] [Related]
12. Genetics of type 2 diabetes and insulin resistance: knowledge from human studies. McIntyre EA; Walker M Clin Endocrinol (Oxf); 2002 Sep; 57(3):303-11. PubMed ID: 12201821 [TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of type 2 diabetes: the relative contribution of insulin resistance and impaired insulin secretion. Groop L Int J Clin Pract Suppl; 2000 Oct; (113):3-13. PubMed ID: 11965829 [TBL] [Abstract][Full Text] [Related]
14. Molecular pathology in the obese spontaneous hypertensive Koletsky rat: a model of syndrome X. Ernsberger P; Koletsky RJ; Friedman JE Ann N Y Acad Sci; 1999 Nov; 892():272-88. PubMed ID: 10842668 [TBL] [Abstract][Full Text] [Related]
15. Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy. Catalano PM; Nizielski SE; Shao J; Preston L; Qiao L; Friedman JE Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E522-33. PubMed ID: 11832353 [TBL] [Abstract][Full Text] [Related]
16. [Insulin resistance and metabolic syndrome]. Joost HG; Giesen K; Kluge R; Ortlepp J; Plum L Z Kardiol; 2000 May; 89(5):377-82. PubMed ID: 10900666 [TBL] [Abstract][Full Text] [Related]
17. [Diagnostic use of gene polymorphism for type 2 diabetes]. Sanke T Rinsho Byori; 2002 Sep; 50(9):871-6. PubMed ID: 12386964 [TBL] [Abstract][Full Text] [Related]
18. The silent PPARgamma exon 6 CAC(His) --> CAT(His) polymorphism does not affect the plasma leptin levels in a collective of first degree relatives of type 2 diabetes patients from South West Germany. Koch M; Rett K; Maerker E; Volk A; Haist K; Deninger M; Rettig A; Renn W; Häring HU Exp Clin Endocrinol Diabetes; 2000; 108(5):341-6. PubMed ID: 10989952 [TBL] [Abstract][Full Text] [Related]